Insolvency regulator to get more teeth, punitive powers; key amendments on the cards
Misha
Shardul Amarchand Mangaldas & Co., along with Goodwin Procter LLP advise Biocon Biologics Limited in its acquisition of the biosimilars business of Viatris Inc., for up to $3.34 billion in stock and cash
Biocon Biologics Limited (“BBL”), a subsidiary of Biocon Limited, announced on February 28, 2022 that it would acquire the biosimilars business of Viatris Inc. (“Viatris”), to create a unique and fully integrated global biosimilars enterprise, in a $3.34 billion deal. BBL will pay Viatris $2 billion in cash and $1 billion in convertible preferred equity… Read More +
Shardul Amarchand Mangaldas advises Upswing Financial Technologies Private Limited in relation to Series Seed fundraise from QED FUND VII, LP and Angel Investors
Shardul Amarchand Mangaldas & Co. advised Upswing Financial Technologies Private Limited in relation to INR 302,000,000 (Indian Rupees Three Hundred Two Million) Series Seed fundraise from QED FUND VII, LP and Angel Investors. The date of signing the deal was 10 December 2021. The Corporate team was led by Sugandha Asthana, Partner; Khushboo Sukhwani,… Read More +
